EP2542249A4 - Methods and compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells - Google Patents

Methods and compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells

Info

Publication number
EP2542249A4
EP2542249A4 EP20100847139 EP10847139A EP2542249A4 EP 2542249 A4 EP2542249 A4 EP 2542249A4 EP 20100847139 EP20100847139 EP 20100847139 EP 10847139 A EP10847139 A EP 10847139A EP 2542249 A4 EP2542249 A4 EP 2542249A4
Authority
EP
European Patent Office
Prior art keywords
tissue
transplanted
inosculation
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP20100847139
Other languages
German (de)
French (fr)
Other versions
EP2542249A1 (en
Inventor
Stuart K Williams
Hyun Joon Paek
Erik Vossman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tissue Genesis Inc
Original Assignee
Tissue Genesis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tissue Genesis Inc filed Critical Tissue Genesis Inc
Priority to EP15164924.1A priority Critical patent/EP2926821B1/en
Publication of EP2542249A1 publication Critical patent/EP2542249A1/en
Publication of EP2542249A4 publication Critical patent/EP2542249A4/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP20100847139 2010-03-05 2010-03-05 Methods and compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells Ceased EP2542249A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP15164924.1A EP2926821B1 (en) 2010-03-05 2010-03-05 Compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2010/026407 WO2011109026A1 (en) 2010-03-05 2010-03-05 Methods and compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP15164924.1A Division EP2926821B1 (en) 2010-03-05 2010-03-05 Compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells

Publications (2)

Publication Number Publication Date
EP2542249A1 EP2542249A1 (en) 2013-01-09
EP2542249A4 true EP2542249A4 (en) 2013-08-07

Family

ID=44542472

Family Applications (2)

Application Number Title Priority Date Filing Date
EP20100847139 Ceased EP2542249A4 (en) 2010-03-05 2010-03-05 Methods and compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells
EP15164924.1A Active EP2926821B1 (en) 2010-03-05 2010-03-05 Compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP15164924.1A Active EP2926821B1 (en) 2010-03-05 2010-03-05 Compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells

Country Status (2)

Country Link
EP (2) EP2542249A4 (en)
WO (1) WO2011109026A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013116327A1 (en) 2012-01-30 2013-08-08 Zahalsky Michael P Methods and compositions for treatment of penile defects
US20180028575A1 (en) 2012-01-30 2018-02-01 Michael Zahalsky Methods and compositions for treatment of penile defects
US20150231182A1 (en) * 2012-09-07 2015-08-20 University Of Louisville Research Foundation, Inc. Cell systems and methods for delivering disease-specific therapies
WO2018065023A1 (en) 2016-10-07 2018-04-12 Coloplast A/S A neophallus implant and a method of implanting a penile prosthetic in a neopenis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514292B1 (en) * 1998-05-21 2003-02-04 Children's Medical Center Corporation Corporal tissue penile reconstruction
EP1908820A1 (en) * 2006-10-06 2008-04-09 Stichting Voor De Technische Wetenschappen Stem cell and/or progenitor cell enrichment

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3949073A (en) 1974-11-18 1976-04-06 The Board Of Trustees Of Leland Stanford Junior University Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5035708A (en) 1985-06-06 1991-07-30 Thomas Jefferson University Endothelial cell procurement and deposition kit
US4820626A (en) 1985-06-06 1989-04-11 Thomas Jefferson University Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surface itself
US5902741A (en) 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
US5266480A (en) 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US5510254A (en) 1986-04-18 1996-04-23 Advanced Tissue Sciences, Inc. Three dimensional cell and tissue culture system
US4963489A (en) 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5863531A (en) 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5041138A (en) 1986-11-20 1991-08-20 Massachusetts Institute Of Technology Neomorphogenesis of cartilage in vivo from cell culture
US4883755A (en) 1987-10-28 1989-11-28 Thomas Jefferson University Method of reendothelializing vascular linings
WO1994000484A1 (en) 1992-06-22 1994-01-06 Young Henry E Scar inhibitory factor and use thereof
US5672346A (en) 1992-07-27 1997-09-30 Indiana University Foundation Human stem cell compositions and methods
US5957972A (en) 1992-09-29 1999-09-28 Arizona Board Of Regents On Behalf Of The University Of Arizona Implants possessing a surface of endothelial cells genetically-modified to inhibit intimal thickening
JP3789930B2 (en) 1992-10-09 2006-06-28 アドバンスド ティシュー サイエンシズ，インコーポレーテッド Liver spare cells
US5514378A (en) 1993-02-01 1996-05-07 Massachusetts Institute Of Technology Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5792603A (en) 1995-04-27 1998-08-11 Advanced Tissue Sciences, Inc. Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing tissue, synthetic or native, vascular grafts
US6121042A (en) 1995-04-27 2000-09-19 Advanced Tissue Sciences, Inc. Apparatus and method for simulating in vivo conditions while seeding and culturing three-dimensional tissue constructs
WO1996039992A1 (en) 1995-06-07 1996-12-19 Advanced Tissue Sciences, Inc. Apparatus and method for sterilizing, seeding, culturing, storing, shipping, and testing replacement cartilage tissue constructs
US5842477A (en) 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
US5763267A (en) 1996-04-16 1998-06-09 Advanced Tissue Sciences Apparatus for the large scale growth and packaging of cell suspensions and three-dimensional tissue cultures
US5827729A (en) 1996-04-23 1998-10-27 Advanced Tissue Sciences Diffusion gradient bioreactor and extracorporeal liver device using a three-dimensional liver tissue
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
US5786207A (en) 1997-05-28 1998-07-28 University Of Pittsburgh Tissue dissociating system and method
CA2307807C (en) 1997-10-23 2008-09-02 Andrea G. Bodnar Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture
US20030082152A1 (en) 1999-03-10 2003-05-01 Hedrick Marc H. Adipose-derived stem cells and lattices
KR100870508B1 (en) 1999-03-10 2008-11-25 유니버시티 오브 피츠버그 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 Adipose-derived stem cells and lattices
EP1325110A4 (en) 2000-10-02 2009-03-25 Thomas F Cannon Automated bioculture and bioculture experiments system
US7052829B2 (en) 2001-03-30 2006-05-30 The Arizona Board Of Regents On Behalf Of The University Of Arizona Prevascularized constructs for implantation to provide blood perfusion
US7029838B2 (en) 2001-03-30 2006-04-18 Arizona Board Of Regents On Behalf Of The University Of Arizona Prevascularized contructs for implantation to provide blood perfusion
US7932084B2 (en) 2005-09-08 2011-04-26 University Of Virginia Patent Foundation Methods and compositions for growing adipose stem cells
US20090227032A1 (en) 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
EP2208786B1 (en) 2005-12-13 2018-08-01 Kyoto University Nuclear reprogramming factor
US20100172883A1 (en) 2007-01-19 2010-07-08 Bruneau Benoit Gaetan Methods of generating cardiomyocytes
US20090304654A1 (en) * 2008-04-30 2009-12-10 Regents Of The University Of California Methods for isolating adipose-derived stem cells and therapeutic use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514292B1 (en) * 1998-05-21 2003-02-04 Children's Medical Center Corporation Corporal tissue penile reconstruction
EP1908820A1 (en) * 2006-10-06 2008-04-09 Stichting Voor De Technische Wetenschappen Stem cell and/or progenitor cell enrichment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2011109026A1 *

Also Published As

Publication number Publication date
EP2926821B1 (en) 2019-12-25
EP2542249A1 (en) 2013-01-09
WO2011109026A1 (en) 2011-09-09
EP2926821A1 (en) 2015-10-07

Similar Documents

Publication Publication Date Title
ZA201804932B (en) Materials and methods to enhance hematopoietic stem cells engraftment procedures
HK1244496A1 (en) Antibodies to muc16 and methods of use thereof
IL214529A0 (en) Bioreactor for the cultivation of mammalian cells and methods of use thereof
EP2421956A4 (en) Compositions and methods for deriving or culturing pluripotent cells
EP2563908A4 (en) Generation of anterior foregut endoderm from pluripotent cells
EP2456856A4 (en) Methods and compositions for improving the viability of cryopreserved cells
HK1186492A1 (en) Differentiation of pluripotent stem cells
HK1175811A1 (en) Induction of pluripotent cells
IL220232A0 (en) Improved methods of cell culture for adoptive cell therapy
IL214818A0 (en) Differentiation of pluripotent cells
IL223527B (en) Generation of induced pluripotent stem cells from small volumes of peripheral blood
IL215581A0 (en) Engineered mesenchymal stem cells and method of using same to treat tumors
HK1185918A1 (en) Dipeptides to enhance yield and viability from cell cultures
SG10201802522SA (en) Treatment of pluripotent cells
EP2638149A4 (en) Immortalization of epithelial cells and methods of use
DK3184109T3 (en) PROCEDURES TO IMPROVE THE PROLIFERATION AND ACTIVITY OF NATURAL KILLER CELLS
EP2600877A4 (en) Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
EP2482761A4 (en) Tissue transplant compositions and methods for use
EP2459707A4 (en) Compositions and methods of preparing alloreactive cytotoxic t cells
EP2591095A4 (en) Direct reprogramming of cells to cardiac myocyte fate
EP2425022A4 (en) Method of preparing autologous cells and method of use for therapy
EP2658369A4 (en) Generation of autologous t-cells in mice
IL217063A0 (en) Generation of induced pluripotent stem cells from cord blood
EP2598150A4 (en) Compositions for proliferation of cells and related methods
EP2531853A4 (en) Use of novel markers of pluripotent stem cells

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20121004

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20130708

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/12 20060101ALI20130702BHEP

Ipc: A61K 35/48 20060101ALI20130702BHEP

Ipc: A61K 35/28 20060101AFI20130702BHEP

Ipc: A61K 35/44 20060101ALI20130702BHEP

17Q First examination report despatched

Effective date: 20140429

RIN1 Information on inventor provided before grant (corrected)

Inventor name: VOSSMAN, ERIK

Inventor name: WILLIAMS, STUART, K.

Inventor name: HOYING, JAMES BEATTY

Inventor name: PAEK, HYUN, JOON

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20150525